Please login to the form below

Not currently logged in
Email:
Password:

Janssen

This page shows the latest Janssen news and features for those working in and with pharma, biotech and healthcare.

Janssen reports positive real-world data for Tremfya in psoriatic arthritis

Janssen reports positive real-world data for Tremfya in psoriatic arthritis

Janssen Pharmaceuticals, a Johnson &Johnson company, has announced positive real-world data for its IL-23 inhibitor Tremfya (guselkumab) in adults with treatment-resistant active psoriatic arthritis (PsA). ... in pain, physical function and fatigue

Latest news

More from news
Approximately 177 fully matching, plus 427 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 63 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 28 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical education website. Support...

Latest intelligence

The evolving healthcare advertising landscape
Industry experts share their insights on the emerging trends in healthcare advertising...
Clinical trial considerations: Why supporting HCPs matters...
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone....
Six ways to provide successful e-learning programs to healthcare professionals
Practical tips to setting up high-impact e-learning programs...